Group photo of leaders, guests and representatives of participating companies
< span>On February 22, the 5th China International Import Expo Medical Industry Communication and Industry Seminar was held at the National Convention and Exhibition Center (Shanghai). This event was hosted by the China International Import Expo Bureau, combining offline and online way to proceed. Liu Fuxue, deputy director of the China International Import Expo Bureau, and Wen Daxiang, director of the Shanghai Municipal Drug Administration, delivered speeches on the spot; Huang Xinyu, deputy director of the Medical Service Department of the National Medical Security Administration, Cao Junshan, deputy director of the Shanghai Municipal Medical Security Administration, and State Drug Administration Jiang Lu (online), Director of the General Office of the Joint Division, Hu Shanlian, Professor of Economics, School of Public Health, Fudan University, the Yangtze River Delta Branch Center for Review and Inspection of the State Food and Drug Administration, the Shanghai Municipal Health Commission, the Shanghai Pharmaceutical Office, and More than 20 exhibitors in the medical exhibition area, including GE Healthcare, Johnson & Johnson, Roche Pharmaceuticals, BD Healthcare, Medtronic, Abbott, Bristol-Myers Squibb, and Eli Lilly, participated in the conference. 
Deputy Director of China International Import Expo Bureau Liu FuxueSpeech< /span>
Shanghai Drug Administration Director Wen Daxiang speaking This seminar builds a platform for outstanding exhibitors and industry supervisors from the fields of pharmaceuticals and medical devices to exchange experience and collide with ideas. All parties focus on innovative product standards. In-depth discussions were held on hot topics such as internationalization and the localization of the industrial chain of foreign companies, promoting the digital transformation of the medical industry, and the prospect of the 5th CIIE. Managing Director of GE Healthcare (China) Co., Ltd. Xu Jun’s speech On the internationalization of innovative product access and the localization of industrial chain layout of foreign companies < span>, Xu Jun, managing director of GE Healthcare (China) Co., Ltd., said that medical imaging is the largest segment of medical devices in China, and the demand for related equipment and professional testing physicians continues to grow. It is hoped that the country will promote the localization of medical devices. At the same time, strengthen the training of local talents. Bian Xin, President of Roche Pharmaceuticals China, expressed the hope that in the negotiation of medical insurance, more consideration can be given to the value of innovative drugs, so as to help innovative drugs achieve more reasonable market access and benefit more patients. Gao Yong, vice president of Bayer (China) Co., Ltd., said that it is recommended to further optimize the negative list in the fields of stem cells, gene therapy and diagnosis, so that more innovative drugs and innovative technologies can benefit Chinese patients. Liu Xiaoli, head of Johnson & Johnson’s regulatory affairs department, said that there is a very urgent clinical need in the field of medicine for common diseases in children in my country, and it is recommended to strengthen innovation and policy support in the field of children’s medicine. 
Speech by Han Wei, Vice President of Johnson & Johnson (Shanghai) Medical Equipment Co., Ltd.
Speech by Liu Xiaoli, Head of Regulatory Affairs Department of Shanghai Johnson & Johnson Pharmaceutical Co., Ltd. < section> About promoting the digital transformation of the medical industry , said Han Wei, Vice President of Johnson & Johnson (Shanghai) Medical Equipment Co., Ltd. The deep integration of medical care is the general direction of the development of the medical industry. During the CIIE, the medical exhibition area also displayed many cutting-edge products and technologies of AI + biomedicine, robotics + medical care. More exhibits on the expo platform become commodities. Zhu Hailuan, Vice President of Sanofi Greater China, said that digitalization has a lot of potential in biomedical R&D and medical application. developing.
Speech by Bian Xin, President of Roche China Prospects for the 5th CIIE , said Long Weili, vice president of Roche Pharmaceuticals China, that as a drug The chairman unit of the special committee, Roche Pharma hopes to hold more industry seminars together with other member units, form a long-term mechanism, strengthen the exchange of government, industry, academia and research, and provide suggestions for the CIIE and the development of the industry. Li Ping, vice president of Bidi Medical Greater China, said that at the 5th CIIE, Bidi and other members of the Medical Device Committee will join hands to introduce more world-leading start-ups to help the innovation and incubation area of the medical exhibition area to improve. new level. Lu Guoping, Vice President of Public Affairs of BioMérieux Greater China, expressed the hope that the CIIE will continue to hold high-end supporting activities such as political and business exchanges, creating opportunities for enterprises to understand the latest industry policies and get opinions and suggestions. Industry supervisory units and specially invited experts present responded to the viewpoints put forward by enterprise representatives in light of the new domestic and international situation and work practice. 
